Production and characterization of murine models of classic and intermediate maple syrup urine disease
2006

Creating Mouse Models for Maple Syrup Urine Disease

publication Evidence: high

Author Information

Author(s): Homanics Gregg E, Skvorak Kristen, Ferguson Carolyn, Watkins Simon, Paul Harbhajan S

Primary Institution: University of Pittsburgh

Hypothesis

The study aims to create genetically engineered murine models that mimic the pathology of classic and intermediate forms of Maple Syrup Urine Disease (MSUD).

Conclusion

The developed mouse models closely approximate the human disease and can be used to test new therapeutic strategies.

Supporting Evidence

  • Knockout mice lacked branched-chain keto acid dehydrogenase activity and had elevated levels of branched-chain amino acids.
  • Transgenic mice expressing human E2 showed reduced but detectable BCKDH activity, allowing survival.
  • The models can be used to test novel therapies for MSUD.

Takeaway

Scientists made special mice that can help us understand a rare disease called Maple Syrup Urine Disease, which affects how the body processes certain proteins.

Methodology

Gene targeting and transgenic technology were used to create mouse models lacking the E2 subunit of branched-chain keto acid dehydrogenase.

Limitations

The models may not fully replicate all aspects of human MSUD due to species differences.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1186/1471-2350-7-33

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication